Market closedNon-fractional
Fortrea Holdings/FTRE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Fortrea Holdings
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Ticker
FTRE
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Durham, United States
Employees
16,000
Website
www.fortrea.com
Fortrea Holdings Metrics
BasicAdvanced
$2.3B
Market cap
-
P/E ratio
-$1.31
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$2.3B
Financial strength
Current ratio
1.471
Quick ratio
1.263
Long term debt to equity
101.049
Total debt to equity
105.43
Interest coverage (TTM)
0.42%
Management effectiveness
Return on assets (TTM)
0.56%
Return on equity (TTM)
-3.65%
Valuation
Price to revenue (TTM)
0.757
Price to book
1.47
Price to tangible book (TTM)
-2.82
Price to free cash flow (TTM)
21.114
Growth
Revenue change (TTM)
2.20%
Earnings per share change (TTM)
-167.62%
What the Analysts think about Fortrea Holdings
Analyst Ratings
Majority rating from 9 analysts.
Fortrea Holdings Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$662M
-14.61%
Net income
-$101M
180.56%
Profit margin
-15.25%
228.66%
Fortrea Holdings Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.24
$0.19
-$0.04
-
Expected
$0.16
$0.24
$0.01
$0.06
Surprise
48.84%
-20.67%
-618.54%
-
Fortrea Holdings News
AllArticlesVideos
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
GlobeNewsWire·1 week ago
Fortrea Appoints Robert Parks as Chief Accounting Officer
GlobeNewsWire·2 weeks ago
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fortrea Holdings stock?
Fortrea Holdings (FTRE) has a market cap of $2.3B as of July 27, 2024.
What is the P/E ratio for Fortrea Holdings stock?
The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of July 27, 2024.
Does Fortrea Holdings stock pay dividends?
No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Fortrea Holdings dividend payment date?
Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.
What is the beta indicator for Fortrea Holdings?
Fortrea Holdings (FTRE) does not currently have a Beta indicator.
Buy or sell Fortrea Holdings stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.